UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study

Therapeutic advances in respiratory disease, 2023-01, Vol.17, p.17534666231167342-17534666231167342

2023

Link zum Volltext

Verfügbarkeit prüfen

Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer

Cancer biology & medicine, 2020-08, Vol.17 (3), p.652-663

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

The lancet oncology, 2015-07, Vol.16 (7), p.830-838

2015

Link zum Volltext

Verfügbarkeit prüfen

Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer

PloS one, 2020-10, Vol.15 (10), p.e0241593-e0241593

2020

Link zum Volltext

Verfügbarkeit prüfen

Cerebral venous thrombosis: comparing characteristics of infective and non-infective aetiologies: a 12-year retrospective study

Postgraduate medical journal, 2015-12, Vol.91 (1082), p.670-674

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, predictors, dynamic bone change, and treatment efficacy of osteoporosis among chronic obstructive pulmonary disease patients: a prospective cohort study

Frontiers in medicine, 2023-08, Vol.10, p.1214277-1214277

2023

Link zum Volltext

Verfügbarkeit prüfen

Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand

Journal of Pathology and Translational Medicine, 2022, 56(3), , pp.126-133

2022

Link zum Volltext

Verfügbarkeit prüfen

Single Nucleotide Polymorphisms in the Gc Gene for Vitamin D Binding Protein in Common Cancers in Thailand

Asian Pacific journal of cancer prevention : APJCP, 2015-04, Vol.16 (8), p.3339-3344

2015

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Hospital Outcome in Patients with Cerebral Venous Thrombosis

Journal of stroke and cerebrovascular diseases, 2014-11, Vol.23 (10), p.2725-2729

2014

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

Journal of clinical oncology, 2023-02, Vol.41 (6), p.1213-1227

2023

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350

2018

Link zum Volltext

Verfügbarkeit prüfen

Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study

Clinical nutrition (Edinburgh, Scotland), 2022-02, Vol.41 (2), p.433-440

2022

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929

2017

Link zum Volltext

Verfügbarkeit prüfen

Utility of prophylactic percutaneous endoscopic gastrostomy tube in head and neck cancer patients undergoing concurrent chemoradiation: A prospective observational cohort

American journal of otolaryngology, 2022-07, Vol.43 (4), p.103512-103512, Article 103512

2022

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

The lancet oncology, 2018-04, Vol.19 (4), p.521-536

2018

Link zum Volltext

Verfügbarkeit prüfen

Predictive and Prognostic Value of TUBB3, RRM1, APE1, and Survivin Expression in Chemotherapy-Receiving Patients with Advanced NonSmall Cell Lung Cancer

Asian Pacific journal of cancer prevention : APJCP, 2023-01, Vol.24 (9), p.3003-3013

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation of the prognostic scoring system for in-hospital mortality prediction in cardiogenic shock patients requiring veno-arterial extracorporeal membrane oxygenation

Asian cardiovascular & thoracic annals, 2023-05, Vol.31 (4), p.321-331

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of pain and efficacy between large-bore and small-bore chest tube drainage for malignant pleural effusion in Songklanagarind Hospital: A randomized controlled trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e19608-e19608

2012

Link zum Volltext

Verfügbarkeit prüfen

Do we need to perform pulmonary function tests in non-small cell lung cancer patients never diagnosed as COPD?

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS9151-TPS9151

2012

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and prognostic value of serum miR‑145 and vascular endothelial growth factor in non‑small cell lung cancer

Oncology letters, 2022-01, Vol.23 (1), p.1, Article 12

2022

Link zum Volltext

Verfügbarkeit prüfen

Blood Eosinophil Count Stability and Clinical Outcomes in Patients With Chronic Obstructive Pulmonary Disease in a High Endemic Area of Parasitic Infection: A Prospective Study

Chronic obstructive pulmonary diseases, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2023-06, Vol.41 (16), p.2869-2876

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(25)
Humans
(23)
Female
(17)
Male
(17)
Oncology
(17)
Middle Aged
(15)
Aged
(13)
Lung Neoplasms - Pathology
(12)
Adult
(11)
Lung Cancer
(10)
Carcinoma, Non-Small-Cell Lung - Pathology
(9)
Lung Neoplasms - Drug Therapy
(9)
Aged, 80 And Over
(8)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(7)
Chemotherapy
(7)
Prognosis
(7)
Cancer Therapies
(6)
Lung Neoplasms - Genetics
(6)
Metastasis
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study

Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer

Cerebral venous thrombosis: comparing characteristics of infective and non-infective aetiologies: a 12-year retrospective study

Prevalence, predictors, dynamic bone change, and treatment efficacy of osteoporosis among chronic obstructive pulmonary disease patients: a prospective cohort study

Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand

Single Nucleotide Polymorphisms in the Gc Gene for Vitamin D Binding Protein in Common Cancers in Thailand

Predictors of Hospital Outcome in Patients with Cerebral Venous Thrombosis

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Utility of prophylactic percutaneous endoscopic gastrostomy tube in head and neck cancer patients undergoing concurrent chemoradiation: A prospective observational cohort

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial

Predictive and Prognostic Value of TUBB3, RRM1, APE1, and Survivin Expression in Chemotherapy-Receiving Patients with Advanced NonSmall Cell Lung Cancer

Validation of the prognostic scoring system for in-hospital mortality prediction in cardiogenic shock patients requiring veno-arterial extracorporeal membrane oxygenation

Comparison of pain and efficacy between large-bore and small-bore chest tube drainage for malignant pleural effusion in Songklanagarind Hospital: A randomized controlled trial

Do we need to perform pulmonary function tests in non-small cell lung cancer patients never diagnosed as COPD?

Diagnostic and prognostic value of serum miR‑145 and vascular endothelial growth factor in non‑small cell lung cancer

Blood Eosinophil Count Stability and Clinical Outcomes in Patients With Chronic Obstructive Pulmonary Disease in a High Endemic Area of Parasitic Infection: A Prospective Study

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer

Suchergebnisse filtern